BCL2 and urinary bladder cancer: As with BCL-2 and MCL-1, for which deregulation of the microRNA control of their expression has been described in cancer, miR-133b deregulation has been observed in bladder cancer, colorectal carcinoma and lung cancer leading to BCL-W overexpression in these cancers [89,90,91].